American Society of Hematology

AML Matters Program

A Multidisciplinary Approach to Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection

AML Matters is an education program designed to improve the diagnosis and treatment of acute myeloid leukemia (AML). The program is being hosted by ASH, American Society for Clinical Pathology, National Marrow Donor Program, Oncology Nursing Society, and The France Foundation.

AML will be diagnosed in approximately 19,950 people in the United States in 2016, and 10,430 patients will die from this disease. Recently, there have been significant advances in the diagnosis and management of AML, which warrant ongoing education for the interdisciplinary care team involved in the management of patients with AML.

This educational program will provide guidance to the interdisciplinary AML care team on the optimal diagnosis and classification of AML, risk stratification, and individualized treatment selection, assessment of treatment responses, monitoring for and mitigation of adverse events, and patient education regarding prognosis and treatment choices.

The target audience for this initiative includes hematology/oncology physicians, advance practice professionals, and nurses; hematopathologists/pathologists; HCT clinicians, and other healthcare professionals.

Participants in the program will attend one of four summits held in North America and will actively engage in multidisciplinary, interactive small-group activities, including:

  • a case-based tumor board
  • diagnosing AML
  • treatment decision-making
  • MRD/CR1 and the role of transplants
  • relapsed refractory disease

Dates and Locations

Denver - AML

Denver, CO

May 3, 2017

Durham - AML

Durham, NC

October 20, 2017
Register now

Minneapolis - AML

Minneapolis, MN

July 28, 2017

Philadelphia - AML

Philadelphia, PA

October 27, 2017
Register now

Steering Committee

  • Jessica Altman, MD (Chair)
    Associate Professor of Medicine Hematology/Oncology
    Northwestern University
    Feinberg School of Medicine
    Chicago, Illinois
  • AnneMarie Block, PhD, FACMG
    Laboratory Director, Cytogenetics Lab
    Department of Pathology and Laboratory Medicine
    Associate Professor of Oncology
    Roswell Park Cancer Institute
    Buffalo, New York
  • Linda Burns, MD
    Vice President and Medical Director of Health Services Research
    National Marrow Donor Program/Be The Match Minneapolis, Minnesota
  • Robert Paul Hasserjian, MD
    Associate Pathologist
    Director, Hematopathology Fellowship Program
    Pathology Service
    Massachusetts General Hospital
    Associate Professor of Pathology
    Harvard Medical School
    Boston, Massachusetts
  • Heidi Klepin, MD
    Associate Professor
    Hematology/Oncology
    Wake Forest Baptist Health
    Winston Salem, North Carolina
  • Bruno Medeiros, MD
    Associate Professor of Medicine
    Hematology
    Stanford University Medical Center
    Stanford, California
  • Martin Tallman, MD
    Chief, Leukemia Service
    Memorial Sloan Kettering Cancer Center
    New York, New York
  • Kathleen Wiley, RN, MSN, AOCNS
    Oncology Clinical Specialist
    Oncology Nursing Society
    Pittsburgh, Pennsylvania
back to top